BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 27511608)

  • 1. Metabolic syndrome and psoriasis severity in South-East Asian patients: An investigation of potential association using current and chronological assessments.
    Chularojanamontri L; Wongpraparut C; Silpa-Archa N; Chaweekulrat P
    J Dermatol; 2016 Dec; 43(12):1424-1428. PubMed ID: 27511608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioelectrical phase angle and psoriasis: a novel association with psoriasis severity, quality of life and metabolic syndrome.
    Barrea L; Macchia PE; Di Somma C; Napolitano M; Balato A; Falco A; Savanelli MC; Balato N; Colao A; Savastano S
    J Transl Med; 2016 May; 14(1):130. PubMed ID: 27165166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and characteristics of metabolic syndrome in South-East Asian psoriatic patients: a case-control study.
    Kokpol C; Aekplakorn W; Rajatanavin N
    J Dermatol; 2014 Oct; 41(10):898-902. PubMed ID: 25201476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome and psoriasis: a study in 97 patients.
    Ferdinando LB; Fukumoto PK; Sanches S; Fabricio LHZ; Skare TL
    Rev Assoc Med Bras (1992); 2018 Apr; 64(4):368-373. PubMed ID: 30133617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of Metabolic Syndrome in Chinese Patients With Erythrodermic Psoriasis: A Case-Control Study.
    Ma AR; Liu F; Wang R; Lin L; Wang Y; Li Q; Lu X; Du J
    Front Endocrinol (Lausanne); 2021; 12():677912. PubMed ID: 34970217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psoriasis, metabolic syndrome and cardiovascular risk factors. A population-based study.
    Fernández-Armenteros JM; Gómez-Arbonés X; Buti-Soler M; Betriu-Bars A; Sanmartin-Novell V; Ortega-Bravo M; Martínez-Alonso M; Garí E; Portero-Otín M; Santamaria-Babi L; Casanova-Seuma JM
    J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):128-135. PubMed ID: 29953676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of metabolic syndrome and cardiovascular changes in patients with chronic plaque psoriasis and their correlation with disease severity: A hospital-based cross-sectional study.
    Kothiwala SK; Khanna N; Tandon N; Naik N; Sharma VK; Sharma S; Sreenivas V
    Indian J Dermatol Venereol Leprol; 2016; 82(5):510-8. PubMed ID: 27297282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutrition: a key environmental dietary factor in clinical severity and cardio-metabolic risk in psoriatic male patients evaluated by 7-day food-frequency questionnaire.
    Barrea L; Macchia PE; Tarantino G; Di Somma C; Pane E; Balato N; Napolitano M; Colao A; Savastano S
    J Transl Med; 2015 Sep; 13():303. PubMed ID: 26376719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome, C-reactive protein and cardiovascular risk in psoriasis patients: a cross-sectional study.
    Paschoal RS; Silva DA; Cardili RN; Souza CDS
    An Bras Dermatol; 2018 Mar; 93(2):222-228. PubMed ID: 29723366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psoriasis Severity-A Risk Factor of Insulin Resistance Independent of Metabolic Syndrome.
    Polic MV; Miskulin M; Smolic M; Kralik K; Miskulin I; Berkovic MC; Curcic IB
    Int J Environ Res Public Health; 2018 Jul; 15(7):. PubMed ID: 30011841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing cardiometabolic risk profile in patients with psoriasis.
    Curcó N; Barriendos N; Barahona MJ; Arteaga C; García M; Yordanov S; De La Barrera O; Prat C; Vives P; Giménez N
    Australas J Dermatol; 2018 May; 59(2):e93-e98. PubMed ID: 28240341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of severity of the cutaneous manifestations and age on the prevalence of several cardiovascular risk factors in patients with psoriasis.
    Rosa DJ; Machado RF; Matias FA; Cedrim SD; Noronha FL; Gaburri D; Gamonal A
    J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):348-53. PubMed ID: 21545540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The increased prevalence of non-alcoholic fatty liver disease in psoriatic patients: a study from South India.
    Madanagobalane S; Anandan S
    Australas J Dermatol; 2012 Aug; 53(3):190-7. PubMed ID: 22672067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of smoking, alcohol consumption and metabolic syndrome in patients with psoriasis.
    Adışen E; Uzun S; Erduran F; Gürer MA
    An Bras Dermatol; 2018 Mar; 93(2):205-211. PubMed ID: 29723384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between the severity of hard-to-treat psoriasis and the prevalence of metabolic syndrome: A hospital-based cross-sectional study in Jakarta, Indonesia.
    Evyana D; Novianto E; Budianti WK; Krisanti RIA; Wisnu W; Wibawanti R; Nilasari H; Legiawati L; Hapsari SAR; Mutmainnah E
    PLoS One; 2024; 19(4):e0302391. PubMed ID: 38683749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic comorbidities and hypertension in psoriasis patients in France. Comparisons with French national databases.
    Phan C; Sigal ML; Lhafa M; Barthélémy H; Maccari F; Estève E; Reguiai Z; Perrot JL; Chaby G; Maillard H; Bégon E; Alexandre M; Toussaint P; Bastien-Jacquin M; Bravard P; Sauque E; de Quatrebarbes J; Pfister P; Beauchet A; Mahé E;
    Ann Dermatol Venereol; 2016 Apr; 143(4):264-74. PubMed ID: 26969480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of metabolic syndrome with serum omentin-1 and visfatin levels and disease severity in psoriasis and psoriatic arthritis.
    Dağdelen D; Karadag AS; Kasapoğlu E; Wang JV; Erman H
    Dermatol Ther; 2020 Nov; 33(6):e14378. PubMed ID: 33029930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of serum uric acid levels in psoriasis vulgaris.
    Yilmaz E; Tamer E; Artüz F; Külcü Çakmak S; Köktürk F
    Turk J Med Sci; 2017 Apr; 47(2):531-534. PubMed ID: 28425242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severity of Psoriasis Differs Between Men and Women: A Study of the Clinical Outcome Measure Psoriasis Area and Severity Index (PASI) in 5438 Swedish Register Patients.
    Hägg D; Sundström A; Eriksson M; Schmitt-Egenolf M
    Am J Clin Dermatol; 2017 Aug; 18(4):583-590. PubMed ID: 28342016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based cross-sectional study.
    Milčić D; Janković S; Vesić S; Milinković M; Marinković J; Ćirković A; Janković J
    An Bras Dermatol; 2017; 92(1):46-51. PubMed ID: 28225956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.